MAPT and prion disease: Microtubule-associated protein tau (or simply “tau”) has several variant forms [10,11]; examined in this study was tau transcript variant 2 (tau-2, GenBank accession NM_005910), routinely used in our laboratory as a biomarker for prion disease diagnosis [12].